Mizzou announced that they received about $700,000 from the National Institutes on Aging for a program that aims to close the gap between academia and industry to meet the needs of an aging society.
Academic researchers and biomedical companies have made great strides to improve the quality of life for the elderly, yet there remains a disconnect that continues to slow the process of getting scientific discoveries from the researchers to patients.
Biomedical Entrepreneurship Training for Aging (BETA) is meant to grow a scientific minded workforce to shorten the time frame between the discovery and commercialization of new drugs, devices and technologies to combat age-related disorders, especially Alzheimer’s disease and related dementias (AD/ADRD).
By 2050, 22% of the population in the United States will be over the age of 65.